Product
M72/AS01E Mycobacterium tuberculosis vaccine
1 clinical trial
1 indication
Indication
HIVClinical trial
A Randomized, Placebo-controlled, Observer-blind, Phase 2 Study to Evaluate Safety and Immunogenicity of the Investigational M72/AS01E Mycobacterium Tuberculosis (Mtb) Vaccine in Virally Suppressed, Antiretroviral-treated Participants With Human Immunodeficiency Virus (HIV)Status: Completed, Estimated PCD: 2022-08-12